OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
This Quarter Return
-2.61%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$174M
AUM Growth
+$174M
(-47%)
Cap. Flow
-$133M
Cap. Flow
% of AUM
-76.43%
Top 10 Holdings %
Top 10 Hldgs %
95.61%
Holding
30
New
4
Increased
6
Reduced
5
Closed
7
Top Buys
| 1 |
Biohaven
BHVN
|
$59.3M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$9.12M |
| 3 |
Pacific Biosciences
PACB
|
$3.42M |
| 4 |
GeneDx Holdings
WGS
|
$1.6M |
| 5 |
ImmunityBio
IBRX
|
$1.57M |
Top Sells
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$181M |
| 2 |
Moderna
MRNA
|
$12.8M |
| 3 |
CFRX
ContraFect Corporation
CFRX
|
$6.05M |
| 4 |
Opko Health
OPK
|
$4.06M |
| 5 |
ProShares UltraPro QQQ
TQQQ
|
$1.93M |
Sector Composition
| 1 | Healthcare | 99% |
| 2 | Industrials | 0.15% |
| 3 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Biohaven
BHVN
$1.63B
| $59.3M | 33.68% | +392,200 | New | +$59.3M |
|
2
QuidelOrtho
QDEL
$1.95B
| $35.7M | 20.27% | 499,263 | – | – |
|
|
MRTX
3
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $21.3M | 12.13% | 305,629 +130,629 | +75% | +$9.12M |
|
|
4
Opko Health
OPK
$1.1B
| $9.64M | 5.48% | 5,102,756 -2,150,000 | -30% | -$4.06M |
|
|
AGEN
5
Agenus
AGEN
$133M
| $9.21M | 5.23% | 4,491,260 -164,872 | -4% | -$338K |
|
|
6
Pacific Biosciences
PACB
$393M
| $8.09M | 4.59% | 1,393,165 +589,320 | +73% | +$3.42M |
|
7
BioCryst Pharmaceuticals
BCRX
$1.74B
| $8M | 4.55% | 635,194 +31,200 | +5% | +$393K |
|
|
8
GeneDx Holdings
WGS
$3.72B
| $7.37M | 4.19% | 8,403,926 +1,818,572 | +28% | +$1.6M |
|
9
Forian
FORA
$61.3M
| $4.72M | 2.68% | 1,408,432 +74,955 | +6% | +$251K |
|
|
AXDX
10
DELISTED
Accelerate Diagnostics
AXDX
| $3.36M | 1.91% | 2,208,872 -236,919 | -10% | -$360K |
|
|
IMMP
11
Immutep
IMMP
$234M
| $2.43M | 1.38% | 1,557,325 | – | – |
|
|
12
ImmunityBio
IBRX
$2.21B
| $1.57M | 0.89% | +315,322 | New | +$1.57M |
|
|
13
ProShares UltraPro QQQ
TQQQ
$26B
| $966K | 0.55% | 50,000 -100,000 | -67% | -$1.93M |
|
|
DMTK
14
DELISTED
DermTech, Inc. Common Stock
DMTK
| $699K | 0.4% | 176,569 -70,000 | -28% | -$277K |
|
15
Biogen
BIIB
$19.4B
| $644K | 0.37% | 2,412 | – | – |
|
16
SPDR S&P Biotech ETF
XBI
$5.07B
| $526K | 0.3% | +6,633 | New | +$526K |
|
|
CANO
17
DELISTED
Cano Health, Inc.
CANO
| $295K | 0.17% | +34,049 | New | +$295K |
|
|
AWH
18
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $271K | 0.15% | 728,100 | – | – |
|
|
VLD
19
DELISTED
Velo3D, Inc.
VLD
| $256K | 0.15% | 65,000 +34,621 | +114% | +$136K |
|
20
Acadia Pharmaceuticals
ACAD
$4.38B
| – | – | 0 | – | – |
|
21
iShares Russell 2000 ETF
IWM
$67B
| – | – | 0 | – | – |
|
|
22
Moderna
MRNA
$9.37B
| – | – | -89,700 | Closed | -$12.8M |
|
23
Pfizer
PFE
$141B
| – | – | 0 | – | – |
|
24
Soleno Therapeutics
SLNO
$3.6B
| – | – | -2,132,000 | Closed | -$394K |
|
25
SPDR S&P 500 ETF Trust
SPY
$658B
| – | – | 0 | – | – |
|